Ranked #3,013 of 8,699 institutional investors
Tetragon Partners GP Ltd
Grand Cayman, E9
$681M
US stock portfolio at live prices · today −$20.8M (−2.97%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $758M
- Change from Q2 2026
- +$143.2M (+23.31%)
- Positions
- 29 · 4 new, 4 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $8.5M of stock. $41.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesPATH 53.6%SLN 7.09%KGEI 4.64%LYFT 2.48%WK 2.13%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| PATH UiPath, Inc. | 32,500,000 | $365M | 53.6% | Added +5% |
| SLN Silence Therapeutics plc | 2,436,051 | $48.3M | 7.09% | Added +219% |
| KGEI Kolibri Global Energy Inc. | 6,834,504 | $31.6M | 4.64% | Unchanged |
| LYFT Lyft, Inc. | 1,000,000 | $16.9M | 2.48% | Unchanged |
| WK Workiva Inc. | 225,000 | $14.5M | 2.13% | Reduced −10% |
| CXM Sprinklr, Inc. | 2,200,000 | $14.3M | 2.11% | Unchanged |
| IONS Ionis Pharmaceuticals, Inc. | 440,930 | $12.0M | 1.76% | Added +354% |
| MBX MBX Biosciences, Inc. | 220,647 | $11.8M | 1.73% | Added +8% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 264,040 | $11.5M | 1.69% | Added +102% |
| AUTL Autolus Therapeutics plc | 9,500,000 | $9.3M | 1.37% | Unchanged |
| DFTX Definium Therapeutics, Inc. | 310,892 | $9.2M | 1.35% | Added +8% |
| IMVT Immunovant, Inc. | 275,219 | $9.0M | 1.31% | Added +8% |
| CLDX Celldex Therapeutics, Inc. | 295,941 | $8.3M | 1.22% | Added +2% |
| ALKT Alkami Technology, Inc. | 650,000 | $8.2M | 1.21% | Added +8% |
| DYN Dyne Therapeutics, Inc. | 511,280 | $8.2M | 1.20% | Added +43% |
| HRMY Harmony Biosciences Holdings, Inc. | 226,677 | $7.5M | 1.10% | Added +13% |
| NBIX Neurocrine Biosciences, Inc. | 47,014 | $7.4M | 1.08% | New |
| RLAY Relay Therapeutics, Inc. | 447,235 | $7.1M | 1.04% | Reduced −22% |
| KRYS Krystal Biotech, Inc. | 19,668 | $6.2M | 0.91% | Unchanged |
| AGIO Agios Pharmaceuticals, Inc. | 215,529 | $6.2M | 0.91% | Added +5% |
| CELC Celcuity Inc. | 87,421 | $4.9M | 0.72% | Added +36% |
| AXSM Axsome Therapeutics, Inc. | 35,000 | $4.7M | 0.70% | New |
| UBER Uber Technologies, Inc. | 71,428 | $4.7M | 0.69% | New |
| NKTR Nektar Therapeutics | 101,645 | $3.3M | 0.49% | Added +17% |
| ANTX AN2 Therapeutics, Inc. | 603,424 | $3.1M | 0.46% | New |
| SNOW Snowflake Inc. | 10,000 | $2.7M | 0.39% | Unchanged |
| ANNX Annexon, Inc. | 655,948 | $2.2M | 0.33% | Reduced −47% |
| TECX Tectonic Therapeutic, Inc. | 26,798 | $564K | <0.1% | Reduced −42% |
| GLUE Monte Rosa Therapeutics, Inc. | 56,052 | $499K | <0.1% | Unchanged |